Banner
  • Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

CCE Cardiometabolic disorders: University of Mississippi by the numbers

Article

The numbers behind the University of Mississippi's cardiometabolic disorders program

The following data were evaluated to determine the University of Mississippi's standing as a Clinical Center of Excellence for cardiometabolic disorders:

2007: Year founded

8: Faculty

8: Research protocols annually

6: Annual faculty publications

75 percent: Patients reaching target LDL levels

50 percent: Patients reaching all target lipid levels

1.5 percent: Average HbA1C reduction

90 percent: Achievement of quality assurance treatment markers such as annual monofilament foot examinations, aspirin therapy, and vaccinations

Related Videos